CN103156461B - 一种治疗颈、腰椎病的中药枕芯及其制备方法 - Google Patents
一种治疗颈、腰椎病的中药枕芯及其制备方法 Download PDFInfo
- Publication number
- CN103156461B CN103156461B CN201310080875.2A CN201310080875A CN103156461B CN 103156461 B CN103156461 B CN 103156461B CN 201310080875 A CN201310080875 A CN 201310080875A CN 103156461 B CN103156461 B CN 103156461B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- neck
- pillow
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 206010041591 Spinal osteoarthritis Diseases 0.000 title abstract 6
- 208000036319 cervical spondylosis Diseases 0.000 title abstract 3
- 208000005801 spondylosis Diseases 0.000 title abstract 3
- 240000008042 Zea mays Species 0.000 claims abstract description 25
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 25
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 25
- 235000005822 corn Nutrition 0.000 claims abstract description 25
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 23
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 23
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 23
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 23
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 23
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 23
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 23
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229940116229 borneol Drugs 0.000 claims abstract description 23
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 23
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 23
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 22
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 22
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 22
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 22
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 22
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 20
- 239000000945 filler Substances 0.000 claims abstract description 8
- 238000011282 treatment Methods 0.000 claims description 33
- 208000029761 vertebral disease Diseases 0.000 claims description 32
- 241000195947 Lycopodium Species 0.000 claims description 21
- 240000007164 Salvia officinalis Species 0.000 claims description 21
- 235000005412 red sage Nutrition 0.000 claims description 21
- 241000723353 Chrysanthemum Species 0.000 claims description 20
- 241000219051 Fagopyrum Species 0.000 claims description 20
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 20
- 241000112528 Ligusticum striatum Species 0.000 claims description 20
- 229940079593 drug Drugs 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 21
- 208000002193 Pain Diseases 0.000 abstract description 19
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 16
- 208000024891 symptom Diseases 0.000 abstract description 7
- 230000003213 activating effect Effects 0.000 abstract description 6
- 230000000704 physical effect Effects 0.000 abstract description 4
- 241000213006 Angelica dahurica Species 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 239000012466 permeate Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 241001532036 Aspidistra Species 0.000 abstract 3
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 2
- 244000130270 Fagopyrum tataricum Species 0.000 abstract 2
- 235000014693 Fagopyrum tataricum Nutrition 0.000 abstract 2
- 241000244365 Ligusticum sinense Species 0.000 abstract 2
- 241000195954 Lycopodium clavatum Species 0.000 abstract 2
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 2
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 description 10
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 206010019233 Headaches Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- AIGAZQPHXLWMOJ-UHFFFAOYSA-N Tanshinone I Chemical compound C1=CC2=C(C)C=CC=C2C(C(=O)C2=O)=C1C1=C2C(C)=CO1 AIGAZQPHXLWMOJ-UHFFFAOYSA-N 0.000 description 4
- -1 alcohol ketone Chemical class 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000003618 Intervertebral Disc Displacement Diseases 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000005505 Measles Diseases 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- 206010028836 Neck pain Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000001467 acupuncture Methods 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 2
- 229960000326 flunarizine Drugs 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- XNGKCOFXDHYSGR-UHFFFAOYSA-N perillene Chemical compound CC(C)=CCCC=1C=COC=1 XNGKCOFXDHYSGR-UHFFFAOYSA-N 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000007958 sleep Effects 0.000 description 2
- 210000001032 spinal nerve Anatomy 0.000 description 2
- 201000005671 spondyloarthropathy Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 210000002385 vertebral artery Anatomy 0.000 description 2
- OGLDWXZKYODSOB-UHFFFAOYSA-N α-phellandrene Chemical compound CC(C)C1CC=C(C)C=C1 OGLDWXZKYODSOB-UHFFFAOYSA-N 0.000 description 2
- IECBDTGWSQNQID-JGVFFNPUSA-N (1r,5s)-4,6,6-trimethylbicyclo[3.1.1]hept-3-en-7-one Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2=O IECBDTGWSQNQID-JGVFFNPUSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- ULDHMXUKGWMISQ-VIFPVBQESA-N (S)-(+)-Carvone Natural products CC(=C)[C@H]1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-VIFPVBQESA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Natural products CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 206010054196 Affect lability Diseases 0.000 description 1
- HKTRVQKOJIKDSB-AGWHVNJWSA-N CC1(C)[C@H](O)[C@H](O)C[C@]2(C)[C@H]3CC[C@H]4[C@@](C)(CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]45C)C=C3CC(=O)[C@@H]12 Chemical compound CC1(C)[C@H](O)[C@H](O)C[C@]2(C)[C@H]3CC[C@H]4[C@@](C)(CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]45C)C=C3CC(=O)[C@@H]12 HKTRVQKOJIKDSB-AGWHVNJWSA-N 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- IECBDTGWSQNQID-UHFFFAOYSA-N Chrysanthenon Natural products CC1=CCC2C(C)(C)C1C2=O IECBDTGWSQNQID-UHFFFAOYSA-N 0.000 description 1
- IECBDTGWSQNQID-SFYZADRCSA-N Chrysanthenone Natural products CC1=CC[C@H]2C(C)(C)[C@@H]1C2=O IECBDTGWSQNQID-SFYZADRCSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000028399 Critical Illness Diseases 0.000 description 1
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- MJRWKTJXJHISTD-UHFFFAOYSA-N Lycoclavanin Natural products CC1C(O)C(O)CC2(C)C3CCC4C(CCC5C(CO)C(O)CCC45C)CC3=CC(=O)C12 MJRWKTJXJHISTD-UHFFFAOYSA-N 0.000 description 1
- 229930194927 Miltionone Natural products 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010058483 Nuchal rigidity Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- OGLDWXZKYODSOB-SNVBAGLBSA-N alpha-phellandrene Natural products CC(C)[C@H]1CC=C(C)C=C1 OGLDWXZKYODSOB-SNVBAGLBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- BCZFSDNVXODRAJ-JTTNIQEDSA-N lycopodine Chemical compound C1CCN2CCC[C@@H]3[C@H]4C[C@@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-JTTNIQEDSA-N 0.000 description 1
- BCZFSDNVXODRAJ-ZHMBSYLPSA-N lycopodine Natural products C1CCN2CCC[C@@H]3[C@H]4C[C@H](C)C[C@]32[C@H]1C(=O)C4 BCZFSDNVXODRAJ-ZHMBSYLPSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N β-pinene Chemical compound C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗颈、腰椎病的中药枕芯,它由下述原料药制备而成:川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花、九龙盘、玉米须和冰片。制备上述中药枕芯的方法,该方法包括以下步骤:1)将川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为填料;2)将九龙盘用玉米须包裹后,捏成圆形块设于枕芯内的正中心位置处,即制成中药枕芯。本发明提供的一种治疗颈、腰椎病的中药枕芯,通过药物直接渗透局部起到活血化瘀、通经活络、消炎镇痛的作用,又通过物理作用对颈椎、腰椎起到一种持续的牵引作用,使多种临床症状消失或减轻;本发明还提供了该枕芯的制备方法,步骤简单、加工成本低。
Description
技术领域
本发明涉及中药枕芯技术领域,尤其是一种用于治疗颈、腰椎病的中药枕芯及其制备方法。
背景技术
颈、腰椎病是一种常见病,多发病,属中医学“痹症”范畴。其主要病理变化为退行性病变引起的椎间盘脱出,椎体曲度变直或反弓,椎间孔狭窄,骨质增生及小关节紊乱,其临床表现十分复杂,主要症状为颈项强直、疼痛、肩臂疼痛、腰痛、下肢疼痛、肢体麻木,活动无力、头痛眩晕、呕吐、视力模糊、耳鸣耳聋、失眠健忘、心悸胸闷以及高血压、冠心病,部分内分泌失调等,其临床表现呈多样化,常易误诊,延误治疗。
目前临床治疗颈、腰椎病的方法较多,主要有输液、牵引、理疗、小针刀、中药离子导入、按摩等非手术治疗,且痛苦大、费用高,又有往返医院之劳,不能达到根除疾病的目的,使患者苦不堪言。
发明内容
本发明所要解决的技术问题是提供一种治疗颈、腰椎病的中药枕芯,通过药物直接渗透局部起到活血化瘀、通经活络、消炎镇痛的作用,又通过物理作用对颈椎、腰椎起到一种持续的牵引作用,能解除脊神经受压及椎动脉扭曲,使多种临床症状消失或减轻;本发明还提供了该中药枕芯的制备方法,步骤简单、制作方便且加工成本低。
为解决上述技术问题,本发明所采用的技术方案是:一种治疗颈、腰椎病的中药枕芯,它由下述重量份的原料药制备而成:
川芎10~50份、红花2~15份、当归15~45份、葛根30~70份、丹参30~70份、伸筋草30~70份、茵陈15~45份、苦荞15~45份、菊花30~70份、九龙盘10~40份、玉米须15~45份、冰片1~5份。
各原料药的优选重量份为:
川芎10~20份、红花2~9份、当归25~35份、葛根45~55份、丹参45~55份、伸筋草45~55份、茵陈25~35份、苦荞25~35份、菊花45~55份、九龙盘15~25份、玉米须25~35份、冰片1~3份。
各原料药的重量份为:
川芎15份、红花5份、当归30份、葛根50份、丹参50份、伸筋草50份、茵陈30份、苦荞30份、菊花50份、九龙盘20份、玉米须30份、冰片1份。
制备上述用于治疗颈、腰椎病的中药枕芯的方法,该方法包括以下步骤:
1)将上述重量份的川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为枕芯中的填料;
2)将上述重量份的九龙盘用玉米须包裹后,捏成圆形块设于枕芯内正中心位置处,即制成本发明所述的用于治疗颈、腰椎病的中药枕芯。
该枕芯的长度为25cm,宽度为8.8cm;可在枕芯外套上枕套,有利于清洗。
本发明各原料药的药理如下:
川芎:含有挥发油,具有活血祛瘀;行气开郁;祛风止痛的作用。
红花:性温,味辛,活血通经、散瘀止痛;适用于经闭、痛经、恶露不行、症瘕痞块。
当归:含有水溶性的有阿魏酸、丁二酸、烟酸、尿嘧啶、腺嘌呤等,具有补血活血,调经止痛,润肠通便的作用;主要用于风湿痹痛、跌扑损伤、痈疽疮疡。
葛根:含多种黄酮类成分,主要活性成分为大豆素、大豆甙、葛根素、葛根素-7-木糖甙等,具有发表解肌,透发麻疹,解热生津,升阳止泻之功效,常用于用于外感发热头痛、项强、口渴、麻疹不透,泄泻、高血压颈项强痛等症。
丹参:含有丹参酮I、丹参II、丹参酮II、丹参新酮及维生素E等,具有活血调经,祛瘀止痛,凉血消痈,清心除烦,养血安神的功效。
伸筋草:含石松碱,棒石松宁碱等生物碱,石松三醇,石松四醇酮等萜类化合物,β-谷甾醇等甾醇,及香草酸,阿魏酸等;具有祛风散寒.除湿消肿,舒筋活络的功效;主要用于风寒湿痹,筋脉拘挛疼痈。外用治跌打扭伤肿痛。
茵陈:含挥发油,油中成分有香芹酮、对-聚伞花素、苎烯、紫苏烯、α-水芹烯、百茵陈里香酚、α-、β-蒎烯、松油醇-4、马鞭草酮、萘、芳甲基苯乙酮等;具有清热利湿;退黄的功效。
苦荞:含有酚类化合物.、D-手性肌醇、弱碱性淀粉、活性蛋白等;具有安神、活气血、降气宽肠、清热肿风痛、祛积化滞、清肠、润肠、通便、止咳、平喘、抗炎、抗过敏、强心、减肥、美容等功效。
菊花:含挥发油,成分主要为龙脑、樟脑、菊油环酮,具有散风清热,平肝明目的功效;用于风热感冒,头痛眩晕,目赤肿痛,眼目昏花。
九龙盘:性微苦,平;具有健胃止痛,续骨生肌的功效,用于健胃止痛,续骨生肌。
玉米须:含有脂肪油、挥发油,树胶样物质、树脂、苦味糖甙、皂甙和生物碱;具有泄热通淋,平肝利胆的功效。
冰片:含有多种萜类成分,具有开窍醒神,清热散毒,明目退翳的功效,主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛。
颈、腰椎病的病因主要是风、寒、湿和急性劳损、慢性劳损三大病因,互为因果关系,加之人体免疫力下降,正如《内经》所说:“正气内存,邪不可干,”导致椎体曲度异常及小关节紊乱,周围组织炎性水肿,该枕直接作用于局部穴位,达到活血化瘀、舒通经络,益气强椎,祛风止痛的作用,结果能解除脊神经受压及椎动脉扭曲,椎体曲度异常,松解肌肉、肌腱的痉挛,缓解肌肉疲劳,使多种临床症状消失或减轻。
枕中的药物,其中川芎、红花、丹参重在活血化瘀,当归养血、活血、补血,葛根、伸筋草舒筋通络,缓痉止痛,菊花清肝明目,玉米须具有降糖、降脂、降压作用,茵陈除湿,同玉米须、伸筋草同用,具有质地柔软、舒松透气、使治疗局部有舒适感,利于血液循环,苦荞含有多种氨基酸和微量元素,对人体有较好的补益作用,九龙盘为土家族草药之中治疗风湿、颈、腰椎病常用之药,具有祛风除湿、活血通络之功效,与冰片同用具有芳香开窍、醒神的作用,也可预防其他药物被虫侵蚀;九龙盘用玉米须包裹后,捏成圆形块设于枕芯内正中心位置处,能挺起脊柱椎体,起到了恢复脊柱的生理曲线和锥肩回复的作用,对颈、腰椎起到了持续牵引的作用。诸药合用,加之益椎枕的物理作用,从而可达到治疗并根治颈、腰椎病的目的。
本发明提供的一种治疗颈、腰椎病的中药枕芯及其制备方法,有益效果如下:
1、整个配方通过药物直接渗透局部起到活血化瘀、通经活络、消炎镇痛的作用,又通过益椎枕的物理作用对颈椎、腰椎起到一种持续的牵引作用,经传感器测定,正确使用本中药枕芯,可对颈椎产生持续3.5公斤的牵引力,特别是对颈、腰椎曲线变直和椎间盘突出,能使椎体曲度恢复正常和椎间盘回缩的作用。
2、本发明的配方选用天然食用植物药为原料,各组分符合药政法规定利用各味中药的综合作用治疗各种颈、腰椎病,对人体无副作用,花费低,无痛苦,携带方便。
本发明中药枕枕芯的使用方法如下:颈椎病患者仰睡时将该药枕枕芯仰睡时枕于颈后,侧身睡时,枕在耳部太阳穴;腰椎病患者仰睡时将该枕枕芯枕在腰部,侧卧时放在身边。
为表明本发明中药枕芯对颈、腰椎病的治疗效果,本发明对8879例使用中药枕芯的颈、腰椎病进行临床追踪观察,观察期为30天一疗程:
其中治愈6720人,有效2147人,无效12人,总有效率为99.8%。
本发明中药枕枕芯的治疗效果还可以从以下典型病例的治疗过程中表明:
典型病例1:覃某,女,51岁,家庭主妇, 症状:以眩晕、欲呕、耳鸣、左侧锁骨疼痛为主要症状,血脂、血糖,头部CT检查,均正常,颈部CT和X片诊断:颈椎曲度变直,3.4.5椎体后缘唇样增生,4/5椎间盘脱出,确诊为颈椎病,每晚服西比灵胶囊1粒,连服3天,同时将本中药枕芯晚上枕于颈部,一天后诸症缓解,三日后上述症状消失,亦如常人。
典型病例2:张某,女,44岁,会计,97年患左下肢坐骨神经痛,经CT确诊为为腰椎4/5、5/S1椎间盘脱出,通过针灸、中药治疗症状有所缓解,但经常复发,后采用睡硬板床,起床时用腰维带固定,睡觉时用本中药枕芯垫在腰椎部位,7天后症状缓解,使用一个疗程后症状消失,至今很少复发,偶有不适或疼痛,将本中药枕芯垫在腰椎部位3天至7天症状消失。
典型病例3:汪某,男,60岁,症状:左上下肢偏瘫,头痛如裂,血压200/120毫米汞柱,病危紧急入院,经CT确诊为高血压、脑溢血,经脱水、降压、止血处理后,病情平稳,入院四天后颈部疼痛,左侧头痛,血压再次升高至190/110毫米汞柱,综合分析,为颈、头部疼痛,使病人烦燥,情绪不稳,导致血压升高,病性反复,每晚服西比灵胶囊1粒,连服3天,同时将患者颈部用手轻轻按拿后,将本中药枕芯枕于颈部,三日后症状缓解,使用一个疗程后恢复情况较好,可由家属搀扶出院。
附图说明
下面结合附图和实施例对本发明作进一步说明:
图1为本发明所制备的中药枕芯的外部示意图。
具体实施方式
实施例1
取川芎10g、红花2g、当归15g、葛根30g、丹参30g、伸筋草30g、茵陈15g、苦荞15g、菊花30g、九龙盘10g、玉米须15g、冰片2g。
上述用于治疗颈、腰椎病的中药枕芯的方法,该方法包括以下步骤:
1)将上述重量的川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为枕芯1中的填料;
2)将上述重量份的九龙盘用玉米须包裹后,捏成圆形块2设于枕芯1内的正中心位置处,即制成本发明所述的用于治疗颈、腰椎病的中药枕芯。
该枕芯的长度为25cm,宽度为8.8cm,如图1所示。
实施例2
取川芎50g、红花15g、当归45g、葛根70g、丹参70g、伸筋草70g、茵陈45g、苦荞45g、菊花70g、九龙盘40g、玉米须45g、冰片5g。
上述用于治疗颈、腰椎病的中药枕芯的方法,该方法包括以下步骤:
1)将上述重量的川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为枕芯1中的填料;
2)将上述重量份的九龙盘用玉米须包裹后,捏成圆形块2设于枕芯1内的正中心位置处,即制成本发明所述的用于治疗颈、腰椎病的中药枕芯。
该枕芯的长度为25cm,宽度为8.8cm,如图1所示。
实施例3
取川芎10g、红花2g、当归25g、葛根45g、丹参45g、伸筋草45g、茵陈25g、苦荞25g、菊花45g、九龙盘15g、玉米须25g、冰片2g。
上述用于治疗颈、腰椎病的中药枕芯的方法,该方法包括以下步骤:
1)将上述重量的川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为枕芯1中的填料;
2)将上述重量份的九龙盘用玉米须包裹后,捏成圆形块2设于枕芯1内的正中心位置处,即制成本发明所述的用于治疗颈、腰椎病的中药枕芯。
该枕芯的长度为25cm,宽度为8.8cm,如图1所示。
实施例4
取川芎20g、红花9g、当归35g、葛根55g、丹参55g、伸筋草55g、茵陈35g、苦荞35g、菊花55g、九龙盘25g、玉米须35g、冰片3g。
上述用于治疗颈、腰椎病的中药枕芯的方法,该方法包括以下步骤:
1)将上述重量的川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为枕芯1中的填料;
2)将上述重量份的九龙盘用玉米须包裹后,捏成圆形块2设于枕芯1内的正中心位置处,即制成本发明所述的用于治疗颈、腰椎病的中药枕芯。
该枕芯的长度为25cm,宽度为8.8cm,如图1所示。
实施例5
取川芎15g、红花5g、当归30g、葛根50g、丹参50g、伸筋草50g、茵陈30g、苦荞30g、菊花50g、九龙盘20g、玉米须30g、冰片1g。
上述用于治疗颈、腰椎病的中药枕芯的方法,该方法包括以下步骤:
1)将上述重量的川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为枕芯1中的填料;
2)将上述重量份的九龙盘用玉米须包裹后,捏成圆形块2设于枕芯1内的正中心位置处,即制成本发明所述的用于治疗颈、腰椎病的中药枕芯。
该枕芯的长度为25cm,宽度为8.8cm,如图1所示。
Claims (4)
1.一种治疗颈、腰椎病的中药枕芯,其特征在于它由下述重量份的原料药制备而成:
川芎10~50份、红花2~15份、当归15~45份、葛根30~70份、丹参30~70份、伸筋草30~70份、茵陈15~45份、苦荞15~45份、菊花30~70份、九龙盘10~40份、玉米须15~45份、冰片1~5份;
制备上述治疗颈、腰椎病的中药枕芯的方法,该方法包括以下步骤:
1)将上述重量份的川芎、红花、当归、葛根、丹参、伸筋草、茵陈、苦荞、菊花和冰片加工成饮片,混合后作为枕芯(1)中的填料;
2)将上述重量份的九龙盘用玉米须包裹后,捏成圆形块(2)设于枕芯(1)内的正中心位置处,即制成本发明所述的用于治疗颈、腰椎病的中药枕芯。
2.根据权利要求1所述的一种治疗颈、腰椎病的中药枕芯,其特征在于各原料药的重量份为:
川芎10~20份、红花2~9份、当归25~35份、葛根45~55份、丹参45~55份、伸筋草45~55份、茵陈25~35份、苦荞25~35份、菊花45~55份、九龙盘15~25份、玉米须25~35份、冰片1~3份。
3.根据权利要求2所述的一种治疗颈、腰椎病的中药枕芯,其特征在于各原料药的重量份为:
川芎15份、红花5份、当归30份、葛根50份、丹参50份、伸筋草50份、茵陈30份、苦荞30份、菊花50份、九龙盘20份、玉米须30份、冰片1份。
4.根据权利要求1所述的用于治疗颈、腰椎病的中药枕芯的方法,其特征在于:该枕芯的长度为25cm,宽度为8.8cm。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310080875.2A CN103156461B (zh) | 2013-03-14 | 2013-03-14 | 一种治疗颈、腰椎病的中药枕芯及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310080875.2A CN103156461B (zh) | 2013-03-14 | 2013-03-14 | 一种治疗颈、腰椎病的中药枕芯及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103156461A CN103156461A (zh) | 2013-06-19 |
| CN103156461B true CN103156461B (zh) | 2015-01-07 |
Family
ID=48580370
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310080875.2A Expired - Fee Related CN103156461B (zh) | 2013-03-14 | 2013-03-14 | 一种治疗颈、腰椎病的中药枕芯及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103156461B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104305791A (zh) * | 2014-10-12 | 2015-01-28 | 马永珍 | 一种治疗颈椎病及肩椎炎的青草药保健枕 |
| CN104815390A (zh) * | 2015-04-02 | 2015-08-05 | 卫景龙 | 一种治疗腰椎病的微化中药分子渗透吸收治疗床 |
| CN105012794B (zh) * | 2015-07-10 | 2018-08-14 | 郎溪县志瑞企业信息服务有限公司 | 颈椎枕芯料组合物 |
| CN104983809B (zh) * | 2015-07-27 | 2018-07-03 | 苏州卫生职业技术学院 | 一种治疗肩周炎的中药组合物及其制备方法 |
| CN112076307A (zh) * | 2020-10-13 | 2020-12-15 | 江俊海 | 一种治疗颈椎、腰椎病的草药药枕 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1175778C (zh) * | 2002-11-12 | 2004-11-17 | 金龙亮 | 治疗颈椎病的药枕 |
| CN1296093C (zh) * | 2005-02-24 | 2007-01-24 | 姜瑛 | 一种颈椎牵引药袋 |
| CN101797293B (zh) * | 2010-04-15 | 2011-08-31 | 南京中医药大学 | 一种治疗颈椎病的中药枕芯及其制备方法 |
| CN101912539B (zh) * | 2010-08-20 | 2012-08-01 | 安徽精方药业股份有限公司 | 一种用于治疗神经根型颈椎病的中药组合物及其制备方法 |
-
2013
- 2013-03-14 CN CN201310080875.2A patent/CN103156461B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103156461A (zh) | 2013-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103156461B (zh) | 一种治疗颈、腰椎病的中药枕芯及其制备方法 | |
| CN103860772A (zh) | 治疗脏腑经脉瘀滞、气血不荣病症的药灸及其制作方法 | |
| CN102028375B (zh) | 一种治疗高血压的药枕 | |
| CN104027409A (zh) | 一种治疗颈椎病的中药组合物 | |
| CN101905011A (zh) | 一种用于治疗颈椎病的中药组合物 | |
| CN103495055A (zh) | 一种用于治疗女性内分泌失调的中药汤剂及制备方法 | |
| CN103285352A (zh) | 一种用于治疗宫寒的外用药垫制备方法 | |
| CN104382434A (zh) | 一种治疗颈椎病的中药枕芯配方 | |
| CN104825956A (zh) | 防治中风、康复筋骨关节的药 | |
| CN108498772A (zh) | 用于全身调理的医用雷火灸组合物及其制备方法 | |
| CN109157084A (zh) | 一种治疗颈椎病的药枕 | |
| CN103230547B (zh) | 一种治疗顽固性呃逆的中药 | |
| CN104547222A (zh) | 一种治疗骨质增生症的中药贴敷剂 | |
| CN105011659A (zh) | 中药u型枕 | |
| CN104490186A (zh) | 一种具有降血压作用的中药枕 | |
| CN104547973A (zh) | 一种治疗胸痹的保健中药及其制作方法 | |
| CN104146818A (zh) | 一种中药眼罩 | |
| CN103961578A (zh) | 一种治疗神经衰弱的中药药酒 | |
| CN102579633A (zh) | 一种治疗产后气虚型恶露不尽的中药组合物及其制备方法 | |
| CN102552863B (zh) | 一种治疗纳呆型臁疮的中药制备方法 | |
| CN104825939A (zh) | 一种治疗腰肌劳损的中药制剂 | |
| CN109464628A (zh) | 一种治疗失眠的中药组合物 | |
| CN106075022A (zh) | 一种治疗新生儿硬肿症的灌肠液 | |
| CN106139102A (zh) | 调养肾的外用中药组合物、其制备方法及使用方法 | |
| CN105232159A (zh) | 一种防治高血压的套盒 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150107 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |